Donation from the Reed Family / Tenaquip Foundation propels research and clinical care at The Neuro
The largest gift towards ALS (Amyotrophic Lateral Sclerosis) research and patient care in Quebec will help to significantly advance understanding of this devastating disease and facilitate the development of treatments and therapies. The $2-million donation by the Reed Family / The Tenaquip Foundation is enabling The Montreal Neurological Institute and Hospital – The Neuro, at McGill University to establish the new Reed Family Motor Neuron Disease Research Unit as well as to expand ALS clinical facilities to enhance services and care for patients.
ALS, commonly known as Lou Gehrig’s disease, is a deadly neurodegenerative disease, affecting approximately 3,000 Canadians. The majority of patients die within 2 to 5 years of their diagnosis. The main symptom is muscle weakness that progressively reaches the point of paralysis and prevents a person from breathing. ALS is a result of the death of motor neurons – nerve cells in the brain and spinal cord that control voluntary muscle movement.
Read the full article over at the McGill Newsroom.